Empery Asset Management, LP reported 34 holdings worth US$96.5M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Empery Asset Management, LP reported 34 holdings worth US$96.5M as of Sep 30, 2026. Largest: X4 Pharmaceuticals, Inc., Empery Digital Inc. and Outlook Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 34
- Value as reported
- US$96.5M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| X4 Pharmaceuticals, Inc. | 9.73M | US$28.2M | 29.2% |
| Empery Digital Inc. | 4.83M | US$14.5M | 15.1% |
| Outlook Therapeutics, Inc. | 21.2M | US$12.2M | 12.6% |
| NervGen Pharma Corp. | 3.31M | US$6.32M | 6.5% |
| CleanCore Solutions Inc. | 20M | US$2.6M | 2.7% |
| Pyxis Oncology, Inc. | 1M | US$2.33M | 2.4% |
| Cellectar Biosciences, Inc. | 955K | US$1.76M | 1.8% |
| Amylyx Pharmaceuticals, Inc. | 60,000 | US$1.75M | 1.8% |
| Dyadic International, Inc. | 3.35M | US$1.49M | 1.5% |
| Tenaya Therapeutics, Inc. | 2.13M | US$1.28M | 1.3% |
| Cyngn Inc. | 1.31M | US$983K | 1.0% |
| Quoin Pharmaceuticals. Ltd | 205K | US$934K | 0.97% |
| Clene Inc. | 222K | US$904K | 0.94% |
| Ur-Energy Inc. | 620K | US$670K | 0.69% |
| Precision BioSciences, Inc. | 102K | US$640K | 0.66% |
| Lantern Pharma Inc. | 543K | US$549K | 0.57% |
| Satellos Bioscience Inc | 58,000 | US$493K | 0.51% |
| One and One Green Technologies. INC | 312K | US$443K | 0.46% |
| Jaguar Uranium Corp. | 346K | US$373K | 0.39% |
| AMC Entertainment Holdings, Inc. | 0 | US$0 | 0.00% |
| Annovis Bio, Inc. | 0 | US$0 | 0.00% |
| BTC Digital Ltd. | 0 | US$0 | 0.00% |
| Rein Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Venu Holding Corporation | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC